Clinical Trials
5
Active:0
Completed:4
Trial Phases
3 Phases
Phase 1:3
Phase 3:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 3
1 (20.0%)Phase 4
1 (20.0%)Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution
- First Posted Date
- 2021-03-10
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Pharmaceutical Project Solutions, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT04792034
PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: RX0041
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2018-04-06
- Lead Sponsor
- Pharmaceutical Project Solutions, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02775955
- Locations
- 🇺🇸
Comprehensive Clinical Researc, Berlin, New Jersey, United States
Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function
- First Posted Date
- 2016-05-18
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Pharmaceutical Project Solutions, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT02775981
- Locations
- 🇺🇸
Comprehensive Clinical Researc, Berlin, New Jersey, United States
Topical Anesthetic for Procedures Through the Nose
Phase 3
Completed
- Conditions
- Drug Reaction to Analgesic Nos
- Interventions
- Drug: RX0041 4%Drug: PlaceboDrug: RX0041 8%
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Pharmaceutical Project Solutions, Inc.
- Target Recruit Count
- 648
- Registration Number
- NCT02667054
- Locations
- 🇺🇸
Aroesty Advocare ENT, Mount Arlington, New Jersey, United States
🇺🇸South Carolina ENT, Columbia, South Carolina, United States
Phase I Pharmacokinetic Study of RX0041-2
Phase 1
Completed
- Conditions
- Drug Reaction to Analgesic Nos
- Interventions
- Drug: RX0041-2
- First Posted Date
- 2016-01-28
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- Pharmaceutical Project Solutions, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02667106
News
No news found